Table 1 Baseline characteristics of the study population
From: Metabolomic characterization of frailty identifies subtype-specific management strategies
Characteristic | Overall N = 160,407 | Non-frail N = 132,211 | Frail N = 28,196 | P-value |
|---|---|---|---|---|
Age (years) | 56.10 (8.09) | 55.69 (8.12) | 58.06 (7.69) | <0.001 |
Male | 74,996.00 (46.75%) | 63,116.00 (47.74%) | 11,880.00 (42.13%) | <0.001 |
White | 152,376.00 (94.99%) | 126,032.00 (95.33%) | 26,344.00 (93.43%) | <0.001 |
Current smoking | 16,012.00 (9.98%) | 11,022.00 (8.34%) | 4990.00 (17.70%) | <0.001 |
Current drinking | 130,937.00 (81.63%) | 112,570.00 (85.14%) | 18,367.00 (65.14%) | <0.001 |
BMI (Kg/m2) | 27.14 (4.70) | 26.50 (4.13) | 30.11 (5.91) | <0.001 |
SBP (mmHg) | 137.46 (18.58) | 137.25 (18.59) | 138.43 (18.47) | <0.001 |
DBP (mmHg) | 82.00 (10.12) | 81.93 (10.05) | 82.37 (10.43) | <0.001 |
ALT (U/L) | 23.23 (13.96) | 22.67 (13.27) | 25.86 (16.61) | <0.001 |
AST (U/L) | 26.09 (10.57) | 25.78 (9.90) | 27.54 (13.18) | <0.001 |
ALP (U/L) | 82.70 (25.60) | 80.96 (24.21) | 90.87 (29.97) | <0.001 |
Cholesterol (mmol/L) | 5.73 (1.13) | 5.79 (1.09) | 5.41 (1.24) | <0.001 |
Direct bilirubin (μmol/L) | 1.74 (0.82) | 1.76 (0.80) | 1.69 (0.88) | <0.001 |
Total bilirubin (μmol/L) | 9.19 (4.47) | 9.36 (4.53) | 8.39 (4.13) | <0.001 |
Triglycerides (mmol/L) | 1.72 (1.02) | 1.65 (0.97) | 2.04 (1.17) | <0.001 |
HbA1c (mmol/mol) | 35.80 (6.56) | 35.08 (5.17) | 39.20 (10.27) | <0.001 |